Wen Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wen Lu has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Jie Zhang
School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China
4 shared publications Jin Wang
School of Pharmacy, Health Science Center, Xi’an Jiaotong University, Xi’an 710061, P. R. China
4 shared publicationsWenjing Ta
School of Pharmacy Health Science Center Xi'an Jiaotong University No. 76, Yanta West Road Xi'an 710061 P. R. China
4 shared publicationsJianxiang Wang
Xi’an Jiaotong University
3 shared publicationsJie Zhang
School of Pharmacy Health Science Center Xi'an Jiaotong University No. 76, Yanta West Road Xi'an 710061 P. R. China
3 shared publicationsQingqing Zhang
School of Pharmacy, Health Science Center, Xi’an Jiaotong University, Xi’an 710061, P. R. China
3 shared publications
Latest Publications
- 2 September 2026
- Published by Taylor & Francis in Nanomedicine
- Vol. 21 (17) , 2525-2540
Fluorescently labeled Angiopep-2-conjugated-PAMAM nanoparticles to evaluate drug brain-targeted delivery performance
1. Glioma accounted for 48.6% of all primary brain and central nervous system malignancies and the five-year survival rate was only 7% [1]. In addition to the necessary surgical treatment, drug the...
- 2 September 2026
- Published by Taylor & Francis in Nanomedicine
- Vol. 21 (17) , 2525-2540
Fluorescently labeled Angiopep-2-conjugated-PAMAM nanoparticles to evaluate drug brain-targeted delivery performance
1. Glioma accounted for 48.6% of all primary brain and central nervous system malignancies and the five-year survival rate was only 7% [1]. In addition to the necessary surgical treatment, drug the...
- 3 April 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (12) , e2500066
Three‐Dimensional Dynamic Blood‐Brain Barrier Model Incorporating Native Cell Culture Systems Based on Shape Memory Biomaterials
An engineered three‐dimensional (3D) dynamic in vitro blood‐brain barrier (BBB) model with vascular‐like architecture and fluid shear forces is integrated. The model is comprised of a supply pool, fluid transport pump, flow chamber, 3D cell‐scaffold, and receiving pool. The flow chamber is designed with three parallel fluid channels connected to the pump and receiving pool, thus simplifying operation and facilitating assembly with standard instruments. A disposable 3D cell‐scaffold made from biocompatible shape memory material can realize configuration transformation from 2D planar structure for cell seeding to 3D tubular structure for cell culture at physiological temperature, which provides cells convenient seeding and desirable attachment. The barrier function of this model is characterized: the maximum transendothelial electrical resistance value is 523 Ω cm2 for co‐cultured cell model; the apparent permeability coefficient of phenol red is in the range of 2.8–3.8 × 10−6 cm−1s; highly expressed BBB‐related proteins (VE‐cadherin, Occludin, Claudin‐5, ZO‐1 and P‐gp) and the polarized transport of P‐gp ligand rhodamine 123 are shown. Further, the differentiating transport characteristics of seven model drugs across BBB are presented using the integrated model. In summary, a high‐fidelity 3D dynamic BBB model, suitable for researching drug trafficking across BBB and developing therapeutics for brain diseases, is constructed.
- 3 April 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (12) , e2500066
Three‐Dimensional Dynamic Blood‐Brain Barrier Model Incorporating Native Cell Culture Systems Based on Shape Memory Biomaterials
An engineered three‐dimensional (3D) dynamic in vitro blood‐brain barrier (BBB) model with vascular‐like architecture and fluid shear forces is integrated. The model is comprised of a supply pool, fluid transport pump, flow chamber, 3D cell‐scaffold, and receiving pool. The flow chamber is designed with three parallel fluid channels connected to the pump and receiving pool, thus simplifying operation and facilitating assembly with standard instruments. A disposable 3D cell‐scaffold made from biocompatible shape memory material can realize configuration transformation from 2D planar structure for cell seeding to 3D tubular structure for cell culture at physiological temperature, which provides cells convenient seeding and desirable attachment. The barrier function of this model is characterized: the maximum transendothelial electrical resistance value is 523 Ω cm2 for co‐cultured cell model; the apparent permeability coefficient of phenol red is in the range of 2.8–3.8 × 10−6 cm−1s; highly expressed BBB‐related proteins (VE‐cadherin, Occludin, Claudin‐5, ZO‐1 and P‐gp) and the polarized transport of P‐gp ligand rhodamine 123 are shown. Further, the differentiating transport characteristics of seven model drugs across BBB are presented using the integrated model. In summary, a high‐fidelity 3D dynamic BBB model, suitable for researching drug trafficking across BBB and developing therapeutics for brain diseases, is constructed.
- 12 January 2024
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 76 (5) , 559-566
Elucidation the mechanism of the active ingredient imperatorin promoting drug absorption in cell model
Imperatorin (IMP) is the main bioactive furanocoumarin of Angelicae dahuricae radix, which is a well-known traditional Chinese medicine. The purpose of this study was to elucidate the role of IMP in promoting absorption and the possible mechanism on the compatible drugs of Angelicae dahuricae radix. The influence of IMP on drugs’ intestinal absorption was conducted by the Caco-2 cell model. The mechanism was studied by investigating the transcellular transport mode of IMP and its influence on P-glycoprotein (P-gp)-mediated efflux, protein expression of P-gp and tight junction, and cell membrane potential. The result showed IMP promoted the uptake of osthole, daidzein, ferulic acid, and puerarin and improved the transport of ferulic acid and puerarin in Caco-2 cells. The absorption-promoting mechanism of IMP might involve the reduction of the cell membrane potential, decrease of P-gp-mediated drug efflux and inhibition of the P-gp expression level in the cellular pathway, and the loosening of the tight junction protein by the downregulation of the expression levels of occludin and claudin-1 in the paracellular pathway. This study provides new insights into the understanding of the improved bioavailability of Angelicae dahuricae radix with its compatible drugs.
- 12 January 2024
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 76 (5) , 559-566
Elucidation the mechanism of the active ingredient imperatorin promoting drug absorption in cell model
Imperatorin (IMP) is the main bioactive furanocoumarin of Angelicae dahuricae radix, which is a well-known traditional Chinese medicine. The purpose of this study was to elucidate the role of IMP in promoting absorption and the possible mechanism on the compatible drugs of Angelicae dahuricae radix. The influence of IMP on drugs’ intestinal absorption was conducted by the Caco-2 cell model. The mechanism was studied by investigating the transcellular transport mode of IMP and its influence on P-glycoprotein (P-gp)-mediated efflux, protein expression of P-gp and tight junction, and cell membrane potential. The result showed IMP promoted the uptake of osthole, daidzein, ferulic acid, and puerarin and improved the transport of ferulic acid and puerarin in Caco-2 cells. The absorption-promoting mechanism of IMP might involve the reduction of the cell membrane potential, decrease of P-gp-mediated drug efflux and inhibition of the P-gp expression level in the cellular pathway, and the loosening of the tight junction protein by the downregulation of the expression levels of occludin and claudin-1 in the paracellular pathway. This study provides new insights into the understanding of the improved bioavailability of Angelicae dahuricae radix with its compatible drugs.
- Open Access
- 1 April 2023
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 18, 1823-1834
Customizable Dual-Fluorescent Nanoparticles for Tracing and Quantifying of Cell Transport
Purpose: Nanotechnology-based drug delivery systems (nano-DDS) have been developed to be a promising strategy to improve the efficacy, safety, physicochemical and pharmacokinetic/pharmacodynamics properties of drugs. It is very necessary to elucidate the delivery process in vivo or in cells for the rational design and accurate preparation of nano-DDS. The aim of this study was to construct a nano-DDS to visualize and quantify the intracellular behavior of the loaded cargo and carrier in such a system. Methods: A carboxyl-terminal end of poly(lactic-co-glycolic acid) polymer was fluorescently labeled with rhodamine B by conjugation of ethylenediamine. Dual-fluorescent nanoparticles (DFPs) were prepared from this fluorescently labeled polymer to encapsulate a fluorescent cargo, coumarin 6. The carrier and cargo of DFPs were monitored by confocal fluorescence microscopy during cellular uptake. Furthermore, the transcellular transportation of DFPs was evaluated quantitatively by measuring the fluorescence intensity. Results: The obtained fluorescent polymer showed stable and quantifiable characteristics. DFPs could be customized in terms of coumarin 6 content (97.7± 1.0%), size (367.3± 1.7 nm) and dual-emission fluorescence (green cargo and red carrier). DFPs did not significantly affect cell viability, the integrity of cell monolayers and the microscopic morphology at concentrations below 0.7 mg/mL within 3 h of co-incubation with Caco-2 cells. Multichannel fluorescence monitoring revealed that the fluorescence intensity of the carrier and cargo increased with time, but not synchronously. By calculating the residual, intracellular, and transport amounts of DFPs, the material balance between the total amount of cellular transport and the dose administered was obtained. Conclusion: Based on the advantages of dual fluorescent labeling, the differential behavior of cell trafficking can be visualized and quantitatively analyzed for the cargo and carrier of DFPs. These results provide insights into the cellular transport process of holistic nanoparticles and complement our understanding of the biological behaviors of nano-DDS.
- 1 April 2023
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 18, 1823-1834
Open AccessCustomizable Dual-Fluorescent Nanoparticles for Tracing and Quantifying of Cell Transport
Purpose: Nanotechnology-based drug delivery systems (nano-DDS) have been developed to be a promising strategy to improve the efficacy, safety, physicochemical and pharmacokinetic/pharmacodynamics properties of drugs. It is very necessary to elucidate the delivery process in vivo or in cells for the rational design and accurate preparation of nano-DDS. The aim of this study was to construct a nano-DDS to visualize and quantify the intracellular behavior of the loaded cargo and carrier in such a system. Methods: A carboxyl-terminal end of poly(lactic-co-glycolic acid) polymer was fluorescently labeled with rhodamine B by conjugation of ethylenediamine. Dual-fluorescent nanoparticles (DFPs) were prepared from this fluorescently labeled polymer to encapsulate a fluorescent cargo, coumarin 6. The carrier and cargo of DFPs were monitored by confocal fluorescence microscopy during cellular uptake. Furthermore, the transcellular transportation of DFPs was evaluated quantitatively by measuring the fluorescence intensity. Results: The obtained fluorescent polymer showed stable and quantifiable characteristics. DFPs could be customized in terms of coumarin 6 content (97.7± 1.0%), size (367.3± 1.7 nm) and dual-emission fluorescence (green cargo and red carrier). DFPs did not significantly affect cell viability, the integrity of cell monolayers and the microscopic morphology at concentrations below 0.7 mg/mL within 3 h of co-incubation with Caco-2 cells. Multichannel fluorescence monitoring revealed that the fluorescence intensity of the carrier and cargo increased with time, but not synchronously. By calculating the residual, intracellular, and transport amounts of DFPs, the material balance between the total amount of cellular transport and the dose administered was obtained. Conclusion: Based on the advantages of dual fluorescent labeling, the differential behavior of cell trafficking can be visualized and quantitatively analyzed for the cargo and carrier of DFPs. These results provide insights into the cellular transport process of holistic nanoparticles and complement our understanding of the biological behaviors of nano-DDS.
- Open Access
- 1 October 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (10) , 2455
A Review on Increasing the Targeting of PAMAM as Carriers in Glioma Therapy
Glioma is an invasive brain cancer, and it is difficult to achieve desired therapeutic effects due to the high postoperative recurrence rate and limited efficacy of drug therapy hindered by the biological barrier of brain tissue. Nanodrug delivery systems are of great interest, and many efforts have been made to utilize them for glioma treatment. Polyamidoamine (PAMAM), a starburst dendrimer, provides malleable molecular size, functionalized molecular structure and penetrable brain barrier characteristics. Therefore, PAMAM-based nanodrug delivery systems (PAMAM DDS) are preferred for glioma treatment research. In this review, experimental studies on PAMAM DDS for glioma therapy were focused on and summarized. Emphasis was given to three major topics: methods of drug loading, linkers between drug/ligand and PAMAM and ligands of modified PAMAM. A strategy for well-designed PAMAM DDS for glioma treatment was proposed. Purposefully understanding the physicochemical and structural characteristics of drugs is necessary for selecting drug loading methods and achieving high drug loading capacity. Additionally, functional ligands contribute to achieving the brain targeting, brain penetration and low toxicity of PAMAM DDS. Furthermore, a brilliant linker facilitates multidrug combination and multifunctional PAMAM DDS. PAMAM DDS show excellent promise as drug vehicles and will be further studied for product development and safety evaluation.
- 1 October 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (10) , 2455
Open AccessA Review on Increasing the Targeting of PAMAM as Carriers in Glioma Therapy
Glioma is an invasive brain cancer, and it is difficult to achieve desired therapeutic effects due to the high postoperative recurrence rate and limited efficacy of drug therapy hindered by the biological barrier of brain tissue. Nanodrug delivery systems are of great interest, and many efforts have been made to utilize them for glioma treatment. Polyamidoamine (PAMAM), a starburst dendrimer, provides malleable molecular size, functionalized molecular structure and penetrable brain barrier characteristics. Therefore, PAMAM-based nanodrug delivery systems (PAMAM DDS) are preferred for glioma treatment research. In this review, experimental studies on PAMAM DDS for glioma therapy were focused on and summarized. Emphasis was given to three major topics: methods of drug loading, linkers between drug/ligand and PAMAM and ligands of modified PAMAM. A strategy for well-designed PAMAM DDS for glioma treatment was proposed. Purposefully understanding the physicochemical and structural characteristics of drugs is necessary for selecting drug loading methods and achieving high drug loading capacity. Additionally, functional ligands contribute to achieving the brain targeting, brain penetration and low toxicity of PAMAM DDS. Furthermore, a brilliant linker facilitates multidrug combination and multifunctional PAMAM DDS. PAMAM DDS show excellent promise as drug vehicles and will be further studied for product development and safety evaluation.
- 3 May 2022
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 33 (5) , 918-928
Discovery of Imaging and Therapeutic Integration Bifunctional Molecules Based on Bio-Orthogonal Reaction and Releasable Disulfide Bond
- 3 May 2022
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 33 (5) , 918-928
Discovery of Imaging and Therapeutic Integration Bifunctional Molecules Based on Bio-Orthogonal Reaction and Releasable Disulfide Bond
- 12 April 2022
- Published by Springer Nature in Topics in Current Chemistry
- Vol. 380 (4) , 1-42
Development and Challenge of Fluorescent Probes for Bioimaging Applications: From Visualization to Diagnosis
Fluorescent probes have been used widely in bioimaging, including biological substance detection, cell imaging, in vivo biochemical reaction process tracking, and disease biomarker monitoring, and have gradually occupied an indispensable position. Compared with traditional biological imaging technologies, such as positron emission tomography (PET) and nuclear magnetic resonance imaging (MRI), the attractive advantages of fluorescent probes, such as real-time imaging, in-depth visualization, and less damage to biological samples, have made them increasingly popular. Among them, ultraviolet–visible (UV–vis) fluorescent probes still occupy the mainstream in the field of fluorescent probes due to the advantages of available structure, simple synthesis, strong versatility, and wide application. In recent years, fluorescent probes have become an indispensable tool for bioimaging and have greatly promoted the development of diagnostics. In this review, we focus on the structure, design strategies, advantages, representative probes and latest discoveries in application fields of UV–visible fluorescent probes developed in the past 3–5 years based on several fluorophores. We look forward to future development trends of fluorescent probes from the perspective of bioimaging and diagnostics. This comprehensive review may facilitate the development of more powerful fluorescent sensors for broad and exciting applications in the future.
- 12 April 2022
- Published by Springer Nature in Topics in Current Chemistry
- Vol. 380 (4) , 1-42
Development and Challenge of Fluorescent Probes for Bioimaging Applications: From Visualization to Diagnosis
Fluorescent probes have been used widely in bioimaging, including biological substance detection, cell imaging, in vivo biochemical reaction process tracking, and disease biomarker monitoring, and have gradually occupied an indispensable position. Compared with traditional biological imaging technologies, such as positron emission tomography (PET) and nuclear magnetic resonance imaging (MRI), the attractive advantages of fluorescent probes, such as real-time imaging, in-depth visualization, and less damage to biological samples, have made them increasingly popular. Among them, ultraviolet–visible (UV–vis) fluorescent probes still occupy the mainstream in the field of fluorescent probes due to the advantages of available structure, simple synthesis, strong versatility, and wide application. In recent years, fluorescent probes have become an indispensable tool for bioimaging and have greatly promoted the development of diagnostics. In this review, we focus on the structure, design strategies, advantages, representative probes and latest discoveries in application fields of UV–visible fluorescent probes developed in the past 3–5 years based on several fluorophores. We look forward to future development trends of fluorescent probes from the perspective of bioimaging and diagnostics. This comprehensive review may facilitate the development of more powerful fluorescent sensors for broad and exciting applications in the future.
- 29 September 2021
- Published by Springer Nature in Topics in Current Chemistry
- Vol. 379 (6) , 1-20
Research Progress and Application of Bioorthogonal Reactions in Biomolecular Analysis and Disease Diagnosis
Bioorthogonal reactions are rapid, specific and high yield reactions that can be performed in in vivo microenvironments or simulated microenvironments. At present, the main biorthogonal reactions include Staudinger ligation, copper-catalyzed azide alkyne cycloaddition, strain-promoted [3 + 2] reaction, tetrazine ligation, metal-catalyzed coupling reaction and photo-induced biorthogonal reactions. To date, many reviews have reported that bioorthogonal reactions have been used widely as a powerful tool in the field of life sciences, such as in target recognition, drug discovery, drug activation, omics research, visualization of life processes or exogenous bacterial infection processes, signal transduction pathway research, chemical reaction dynamics analysis, disease diagnosis and treatment. In contrast, to date, few studies have investigated the application of bioorthogonal reactions in the analysis of biomacromolecules in vivo. Therefore, the application of bioorthogonal reactions in the analysis of proteins, nucleic acids, metabolites, enzyme activities and other endogenous molecules, and the determination of disease-related targets is reviewed. In addition, this review discusses the future development opportunities and challenges of biorthogonal reactions. Graphic Abstract This review presents an overview of recent advances for application in biomolecular analysis and disease diagnosis, with a focus on proteins, metabolites and RNA detection.
- 29 September 2021
- Published by Springer Nature in Topics in Current Chemistry
- Vol. 379 (6) , 1-20
Research Progress and Application of Bioorthogonal Reactions in Biomolecular Analysis and Disease Diagnosis
Bioorthogonal reactions are rapid, specific and high yield reactions that can be performed in in vivo microenvironments or simulated microenvironments. At present, the main biorthogonal reactions include Staudinger ligation, copper-catalyzed azide alkyne cycloaddition, strain-promoted [3 + 2] reaction, tetrazine ligation, metal-catalyzed coupling reaction and photo-induced biorthogonal reactions. To date, many reviews have reported that bioorthogonal reactions have been used widely as a powerful tool in the field of life sciences, such as in target recognition, drug discovery, drug activation, omics research, visualization of life processes or exogenous bacterial infection processes, signal transduction pathway research, chemical reaction dynamics analysis, disease diagnosis and treatment. In contrast, to date, few studies have investigated the application of bioorthogonal reactions in the analysis of biomacromolecules in vivo. Therefore, the application of bioorthogonal reactions in the analysis of proteins, nucleic acids, metabolites, enzyme activities and other endogenous molecules, and the determination of disease-related targets is reviewed. In addition, this review discusses the future development opportunities and challenges of biorthogonal reactions. Graphic Abstract This review presents an overview of recent advances for application in biomolecular analysis and disease diagnosis, with a focus on proteins, metabolites and RNA detection.
- 23 August 2021
- Published by Wiley in Drug Development Research
- Vol. 83 (2) , 368-378
Effective and transient mapping of protein–protein interactions: Application of novel releasable photoaffinity linkers
Herein, two novel multifunctional releasable photoaffinity linkers were developed for effective and transient tracking interacting proteins with the overall objective of understanding their in vivo biological functions in real‐time. These linkers could be used for the chemical modification of protein under moderate experimental conditions to form protein photoaffinity probes. These probes incorporated with both photoaffinity labels and tag‐transfer, enable photo‐crosslinking of bait proteins along with the release of unrelated groups. These photoaffinity linkers can be utilized to construct probes for disease markers, which could enable rapid diagnosis in a clinical setting at minimal interference with normal physiology.
- 23 August 2021
- Published by Wiley in Drug Development Research
- Vol. 83 (2) , 368-378
Effective and transient mapping of protein–protein interactions: Application of novel releasable photoaffinity linkers
Herein, two novel multifunctional releasable photoaffinity linkers were developed for effective and transient tracking interacting proteins with the overall objective of understanding their in vivo biological functions in real‐time. These linkers could be used for the chemical modification of protein under moderate experimental conditions to form protein photoaffinity probes. These probes incorporated with both photoaffinity labels and tag‐transfer, enable photo‐crosslinking of bait proteins along with the release of unrelated groups. These photoaffinity linkers can be utilized to construct probes for disease markers, which could enable rapid diagnosis in a clinical setting at minimal interference with normal physiology.
- Open Access
- 13 April 2021
- Published by Wiley in Drug Development Research
- Vol. 82 (8) , 1124-1130
Potential antiviral activity of isorhamnetin against SARS‐CoV‐2 spike pseudotyped virus in vitro
Coronavirus Disease 2019 (COVID‐19) cases and deaths are still rising worldwide, there is currently no effective treatment for severe inflammation and acute lung injury caused by new coronavirus (SARS‐COV‐2) infection. Therapies to prevent or treat COVID‐19, including antiviral drug and several vaccines, are still being development. Human angiotensin‐converting enzyme 2 (ACE2), expressing in lung, has been confirmed to be a receptor for SARS‐COV‐2 infection, interventions for attachment of spike protein of SARS‐CoV‐2 to ACE2 may be a potential approach to prevent viral infections and it is considered as a potential target for drug development. In this study, we observed that seabuckthorn and its flavonoid compounds quercetin and isorhamnetin were shown strong retention to ACE2 overexpression HEK293 (ACE2h) cells by CMC analysis. Based on drug receptor interaction analysis and viral entry studies in vitro, we evaluated the interaction of two flavonoid compounds and ACE2 as well as the inhibitory effect of the two compounds on viral entry. Surface plasmon resonance assay proved the effect that isorhamnetin bound to the ACE2, and its affinity (KD value) was at the micromolar level, that was, 2.51 ± 0.68 μM. Viral entry studies in vitro indicated that isorhamnetin inhibited SARS‐CoV‐2 spike pseudotyped virus entering ACE2h cells. Based on promising in vitro results, we proposed isorhamnetin to be a potential therapeutic candidate compound against COVID‐19.
- 13 April 2021
- Published by Wiley in Drug Development Research
- Vol. 82 (8) , 1124-1130
Open AccessPotential antiviral activity of isorhamnetin against SARS‐CoV‐2 spike pseudotyped virus in vitro
Coronavirus Disease 2019 (COVID‐19) cases and deaths are still rising worldwide, there is currently no effective treatment for severe inflammation and acute lung injury caused by new coronavirus (SARS‐COV‐2) infection. Therapies to prevent or treat COVID‐19, including antiviral drug and several vaccines, are still being development. Human angiotensin‐converting enzyme 2 (ACE2), expressing in lung, has been confirmed to be a receptor for SARS‐COV‐2 infection, interventions for attachment of spike protein of SARS‐CoV‐2 to ACE2 may be a potential approach to prevent viral infections and it is considered as a potential target for drug development. In this study, we observed that seabuckthorn and its flavonoid compounds quercetin and isorhamnetin were shown strong retention to ACE2 overexpression HEK293 (ACE2h) cells by CMC analysis. Based on drug receptor interaction analysis and viral entry studies in vitro, we evaluated the interaction of two flavonoid compounds and ACE2 as well as the inhibitory effect of the two compounds on viral entry. Surface plasmon resonance assay proved the effect that isorhamnetin bound to the ACE2, and its affinity (KD value) was at the micromolar level, that was, 2.51 ± 0.68 μM. Viral entry studies in vitro indicated that isorhamnetin inhibited SARS‐CoV‐2 spike pseudotyped virus entering ACE2h cells. Based on promising in vitro results, we proposed isorhamnetin to be a potential therapeutic candidate compound against COVID‐19.